Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Dysphagia Supplements Market: By Product Type, By Distribution Channel, and By Geography
Dysphagia Supplements Market: By Product Type, By Distribution Channel, and By Geography
Dysphagia Supplements Market size was valued at US$ 1032.1 million in 2023 and is expected to reach US$ 1504.6 million by 2030, at a CAGR of 5.7% from 2024 to 2030. Dysphagia is referred as symptoms of difficulty & pain in swallowing. Furthermore, in some cases, swallowing may be impossible. Difficulty in swallowing may occur in fast eating and food is not chewed properly. But persistent dysphagia is a serious condition that needs treatment. Dysphagia occurs at any age but more common in older adults. Other symptoms may include drooling, regurgitations, frequent heartburn, and others. There are two types of dysphagia, esophageal and oropharyngeal and many of the causes such as radiation therapy, scleroderma, neuronal disorders, and esophageal tumors and other many causes lead to dysphagia.
The Dysphagia Supplements market is expected to grow at significant rates owing to the factors such as esophageal cancer and the growing aging population. According to World Health Organization (WHO), in 2010, an estimated 524 million people are aged over 65 and it is expected to triple its number 1.5 billion in 2050. The marketplace has many strong players and scattered globally. Companies are collaborating the hospitals and nursing homes in the dysphagia supplements market. Furthermore, new product development and mergers and acquisitions are key strategies adopted by the companies in the regions for expanding their global presence.
Study Period
2024-2030Base Year
2023CAGR
5.7%Largest Market
North-AmericaFastest Growing Market
Europe
Increase in prevalence of the aging population and esophageal cancer cases who are susceptible to dysphagia is expected to drive the Dysphagia Supplements Market over the forecast period. In addition, dysphagia is one of the major side effects seen in chain smokers. World Health Organization estimates that there are nearly 6 million people lose their lives due to tobacco every year. Furthermore, increase in neurological strokes expected to further push the market growth. However, lack of standard tests for dysphagia and lack of awareness are expected to hamper the market growth during the forecast period.
Geographically dysphagia supplements market is segmented as Latin America, Europe, Asia- Pacific, North America, and The Middle East & Africa. Europe is expected to grow at significant rates owing to rise in aging population, well-developed infrastructure and increase in tobacco usage. North America market is expected to grow at notable rates owing to factors such as widespread of awareness, aging population, and presence of many players in the region. Asia Pacific expected to grow at fastest rates owing to developing infrastructure, increase in healthcare expenditure and growing awareness.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1032.1 million |
|
Market Size in 2030 |
US$ 1504.6 million |
|
Market CAGR |
5.7% |
|
By Product Type |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The dysphagia supplements market size was valued at US$ 1032.1 million in 2023
The dysphagia supplements market key players are: Kent Precision Foods Group, Inc. (Kent Corporation) (U.S.) Abbott Laboratories (U.S.) Nestl Health Science France. (Nestl S.A) (Switzerland) Danone S.A. (France) Nutri Co., Ltd.( Mitsui Sugar ) (Japan) Kissei Pharmaceutical Co., Ltd. (Japan) Saraya Co., Ltd. (Japan) Kewpie Corporation (Japan) Healthy Food Co., Ltd. (Japan)
The dysphagia supplements market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.